Continuum Advisory’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9
| Closed | -$1.36K | – | 643 |
|
|
2025
Q1 | $1.36K | Sell |
9
-9
| -50% | -$1.36K | ﹤0.01% | 1452 |
|
|
2024
Q4 | $3.32K | Hold |
18
| – | – | ﹤0.01% | 1251 |
|
|
2024
Q3 | $3.54K | Buy |
18
+2
| +13% | +$394 | ﹤0.01% | 1254 |
|
|
2024
Q2 | $3.31K | Hold |
16
| – | – | ﹤0.01% | 1180 |
|
|
2024
Q1 | $3.68K | Buy |
+16
| New | +$3.68K | ﹤0.01% | 1137 |
|
|
2023
Q3 | – | Sell |
-997
| Closed | -$210K | – | 455 |
|
|
2023
Q2 | $210K | Buy |
+997
| New | +$210K | 0.03% | 425 |
|
|
2022
Q3 | – | Sell |
-1,130
| Closed | -$242K | – | 408 |
|
|
2022
Q2 | $242K | Sell |
1,130
-296
| -21% | -$63.4K | 0.04% | 362 |
|
|
2022
Q1 | $344K | Buy |
1,426
+781
| +121% | +$188K | 0.07% | 292 |
|
|
2021
Q4 | $243K | Sell |
645
-97
| -13% | -$36.5K | 0.05% | 265 |
|
|
2021
Q3 | $306K | Hold |
742
| – | – | 0.08% | 223 |
|
|
2021
Q2 | $274K | Buy |
+742
| New | +$274K | 0.09% | 222 |
|